Compare Medpace Holdings Inc (MEDP) vs GraniteShares 2x Long NVDA Daily ETF (NVDL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medpace Holdings Inc vs GraniteShares 2x Long NVDA Daily ETF — how do they compare? Medpace Holdings Inc trades at $612.05 (market cap $16.82B), while GraniteShares 2x Long NVDA Daily ETF trades at $36.86 (market cap $3.56B). The key difference: Medpace Holdings Inc is far larger — about 4.7× GraniteShares 2x Long NVDA Daily ETF's market cap, and Medpace Holdings Inc is trading nearer its 52-week high, GraniteShares 2x Long NVDA Daily ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Medpace Holdings Inc for 14 Days and GraniteShares 2x Long NVDA Daily ETF for 15 Days on average.
| MEDP | NVDL | |
|---|---|---|
Market Cap | $16.82B | $3.56B |
Volume | 223,093 | 9,740,643 |
Sector | Health | Leveraged / Inverse |
52-Week High | $630.19 | $43.02 |
52-Week Low | $393.42 | $21.76 |
Typical Hold Time | 14 Days | 15 Days |
Enterprise Value | $16.44B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Medpace (MEDP) trades at $602.70, down 0.26% with neutral technical signals. The stock shows strong fundamentals with consistent earnings beats (Q4 2025-Q2 2026) and robust profitability (17.67% net margin, 162.15% ROE). Recent CEO stock sales and mixed institutional activity create near-term uncertainty, though analyst consensus remains positive with a $620.44 price target. The company is scheduled to report Q3 2026 results on October 21, 2026.
MEDP presents a compelling growth story with strong financial metrics, though elevated valuations (P/E 35.41) and insider selling warrant caution. Upside potential exists if Q3 earnings meet expectations, while failure to maintain growth momentum could pressure the stock. The current price near pivot point ($599) suggests balanced risk-reward ahead of earnings.
NVDL (GraniteShares 2x Long NVDA Daily ETF) trades at $37.28, down 5.79% in the last session. Technical indicators show a bullish bias with moving averages supporting upward momentum while oscillators remain neutral. The ETF provides 2x daily leveraged exposure to NVIDIA, which continues to dominate AI chip markets with strong earnings performance. Recent news highlights ongoing M&A activity in the ETF space and continued AI sector strength.
The outlook remains positive given NVIDIA's market leadership and AI growth trajectory, though leveraged ETF structure introduces volatility risks. Key opportunities include continued AI adoption and NVIDIA's execution, while risks involve leverage decay and sector concentration. Current technical setup suggests potential for recovery toward resistance levels near $39-41 if bullish momentum resumes.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →About GraniteShares 2x Long NVDA Daily ETF
NVDL is a leveraged ETF that seeks daily investment results corresponding to 200% (2x) of the daily performance of NVIDIA Corporation (NVDA) stock. It is designed as a tactical trading tool for investors with a strong bullish (long) view on NVDA. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment, as its performance over longer periods may significantly deviate from two times the performance of the NVDA stock.
Read more on NVDL →
